Indegene IPO Review

 
Indegene IPO Review

IPO Open Date: May 6, 2024

IPO Close Date: May 8, 2024

IPO Price: ₹430 to ₹452 per share

Lot Size: 33 Shares

Listing: May 13, 2024

Indegene is scheduled to hit the market on May 06, 2024 and close on May 08, 2024. Indegene plans to raise around ₹1,841.76 Cr through an IPO with a sale of up to 40,746,891 equity shares of ₹2 each. The Retail offered 35%, QIB Shares Offered 50%, HNI Shares Offered 15%.

Indegene, established in 1998, specializes in offering digital services tailored for the life sciences sector. Their wide-ranging expertise includes aiding in drug development, overseeing clinical trials, managing regulatory submissions, ensuring pharmacovigilance, handling complaints, and providing sales and marketing support. The company's services are categorized into Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical Solutions, and Enterprise Clinical Solutions. Additionally, they offer consultancy services to further assist life sciences companies in navigating digital transformations for enhanced customer experiences.

Under the brand “DT Consulting,” a subsidiary of Indegene Limited named DT Associates Limited extends consulting services to aid life sciences enterprises in effectively managing their digital evolution endeavors. Noteworthy accolades include the Platinum Level award received at the 2023 Healthy Workplace Conference and Awards, presented by Arogya World India Trust in collaboration with the Public Health Foundation of India. As of December 31, 2023, Indegene Limited boasted an active clientele of 65 companies benefitting from their services and employed a global workforce totaling 5,181 individuals. The majority of their workforce is based in India (4,461 employees), with others distributed across North America (530 employees), Europe (105 employees), China (73 employees), and other regions (12 employees).

Indegene



Indegene IPO Details

Indegene IPO opens on May 06, 2024, and closes on May 08, 2024. The Listing date for Indegene IPO is on May 13, 2024. The price band for IPO is ₹430 to ₹452 per share and lot size of 33 Shares.

IPO DateMay 06, 2024 to May 08, 2024
Listing DateMay 13, 2024
Price₹430 to ₹452 per share
Lot Size33 Shares
Issue Size₹1,841.76 Cr
Face Value₹2 per share

Indegene IPO Tentative Timetable

Indegene opening date is May 06, 2024 and close date is May 08, 2024. The IPO allotment date is May 09, 2024. The refund initiation of IPO is on May 10, 2024. The credit of shares in demat account is on May 10, 2024. The listing date is on May 13, 2024.

EventDate
IPO OpeningMay 06, 2024
IPO ClosingMay 08, 2024
IPO Allotment DateMay 09, 2024
Refund InitiationMay 10, 2024
Shares Credit to DematMay 10, 2024
Lisiting DateMay 13, 2024

Indegene IPO Lot Size

Lot Size of this IPO is 33 shares. A retail-individual investor can apply for up to 13 lots (429 shares or ₹193,908).

CategoryLotsSharesAmount
Retail(Minimum)133₹14,916
Retail(Maximum)13429₹193,908
S-HNI (Minimum)14462₹208,824
B-HNI (Minimum)682244₹1,014,288

Indegene IPO Promoter Holding

Pre Issue Share Holding30.71%
Post Issue Share Holding

Indegene IPO Review

Indegene Ltd. is making waves with its upcoming IPO, offering a unique opportunity in the digital-led commercialization services sector within the Life Science Industry. The company has a stronghold in its market, boasting a virtual monopoly and consistent growth in revenue and profits over the years. With a focus on assisting life sciences companies in various crucial aspects such as drug development, regulatory submissions, and sales and marketing, Indegene Ltd. has positioned itself as a key player at the intersection of healthcare and technology.

The IPO details reveal that the company is issuing a combination of fresh equity shares and an offer for sale, aiming to raise significant capital for further expansion and development. The pricing of the shares appears to be on the higher side based on FY24 earnings, but considering the niche market position and growth potential, it presents a promising investment opportunity for those eyeing medium to long-term gains. Investors looking to capitalize on the booming life sciences industry and digital transformation trends may find value in subscribing to this IPO.

With a strong track record of financial performance and a strategic focus on addressing the evolving needs of life sciences enterprises, Indegene Ltd. stands out as a compelling investment choice in the current market scenario. The company's unique business model, coupled with its established client relationships and global revenue presence, underscores its potential for sustained growth in the coming years. For investors seeking exposure to a dynamic and innovative segment poised for substantial growth, this IPO could be the gateway to promising returns and strategic diversification in their investment portfolio.

Indegene IPO Subscription Status (Bidding Details)

Table not found

Indegene IPO Broker Recommendations

  • Capital Market: To be updated soon
  • Anand Rathi: To be updated soon
  • SMC Global: To be updated soon
  • Arihant Capital: To be updated soon

Indegene IPO FAQs

What is Indegene IPO?

Indegene is issuing 40,746,891 equity shares with a face value of ₹2 each, totaling up to ₹1,841.76 Cr. The shares are being offered at a price of ₹430 to ₹452 each, with a minimum order quantity of 33 shares.

Link Intime India Private Ltd is the registrar for the IPO, and the shares are planned to be listed on the BSE and NSE.

When Indegene IPO will open?

Indegene will open on May 06, 2024 for QIB, NII, and Retail Investors.

When Indegene IPO will end?

Indegene will end on May 08, 2024.

What is Indegene IPO Size?

Indegene IPO size is 1,841.76 Cr.

What is Indegene IPO Price Band?

Indegene price band is 430 to ₹452 per share.

What is the Indegene IPO Allotment Date?

Indegene allotment date is May 09, 2024.

What is the Indegene IPO Listing Date?

Indegene listing date is May 13, 2024. The IPO is to be listed on BSE and NSE.

How to Indegene IPO through Zerodha?

To apply for the IPO “Indegene” on Zerodha, log in to the Zerodha website or app, go to the Portfolio section, and click on IPO. Then, click on the “Apply” button and enter your UPI ID, the desired quantity, and the price. Submit the IPO application form and then approve the mandate on your UPI app. To complete the process, you should have an demat account. If you don't have one, open a demat account with Zerodha.

How to Apply Indegene IPO through Upstox?

To apply for the IPO “Indegene” on Upstox, log in to the Upstox website or app, click on IPO. Then, click on the “Apply” button and enter your UPI ID, the desired quantity, and the price. Submit the IPO application form and then approve the mandate on your UPI app. To complete the process, you should have an demat account. If you don't have one, open a demat account with Upstox.

How to check Indegene IPO Allotment Status?

For Indegene IPO Allotment status check you can visit this link, select the desired IPO and enter your PAN to check the allotment status.

What is Indegene IPO GMP?

You can check out here: Indegene IPO GMP

Sharing Is Caring:
Avatar of Ishika Agarwal
About Ishika Agarwal

Ishika Agarwal is a seasoned financial writer with a strong background in the stock market and investment sector. Ishika has a passion for analyzing and interpreting complex financial data to provide valuable insights to her readers.

Leave a Comment